Literature DB >> 12214281

Characterization of a 500 kb region on 17q25 and the exclusion of candidate genes as the familial Tylosis Oesophageal Cancer (TOC) locus.

Janet M Risk1, Kathryn E Evans, Joanne Jones, Joanne E Langan, Lyn Rowbottom, Fiona E McRonald, Helen S Mills, Anthony Ellis, Joan M Shaw, Irene M Leigh, David P Kelsell, John K Field.   

Abstract

The locus for a syndrome of focal palmoplantar keratoderma (Tylosis) associated with squamous cell oesophageal cancer (TOC) has been mapped to chromosome 17q25, a region frequently deleted in sporadic squamous cell oesophageal tumours. Further haplotype analysis described here, based on revised maps of marker order, has reduced the TOC minimal region to a genetic interval of 2 cM limited by the microsatellite markers D17S785 and D17S751. Partial sequence data and complete physical maps estimate the actual size of this region to be only 0.5 Mb. This analysis allowed the exclusion of proposed candidate tumour suppressor genes including MLL septin-like fusion (MSF), survivin, and deleted in multiple human cancer (DMC1). Computer analysis of sequence data from the minimal region identified 13 candidate genes and the presence of 50-70 other 'gene fragments' as ESTs and/or predicted exons and genes. Ten of the characterized genes were assayed for mutations but no disease-specific alterations were identified in the coding and promoter sequences. This region of chromosome 17q25 is, therefore, relatively gene-rich, containing 13 known and possibly as many as 50 predicted genes. Further mutation analysis of these predicted genes, and others possibly residing in the region, is required in order to identify the elusive TOC locus.

Entities:  

Mesh:

Year:  2002        PMID: 12214281     DOI: 10.1038/sj.onc.1205768

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

1.  Cytoglobin, the newest member of the globin family, functions as a tumor suppressor gene.

Authors:  Narayan Shivapurkar; Victor Stastny; Naoki Okumura; Luc Girard; Yang Xie; Clemens Prinsen; Frederik B Thunnissen; Ignacio I Wistuba; Bogdan Czerniak; Eugene Frenkel; Jack A Roth; Triantafillos Liloglou; George Xinarianos; John K Field; John D Minna; Adi F Gazdar
Journal:  Cancer Res       Date:  2008-09-15       Impact factor: 12.701

2.  Survivin promoter -31G/C polymorphism in oral cancer cell lines.

Authors:  Salvatore de Maria; Lorenzo Lo Muzio; Alessandra Braca; Paolo Rega; Amalia Cassano; Angela Vinella; Ruggiero Fumarulo; Rosario Serpico; Ernesto Farina; Vittoria Metafora; Giuseppe Pannone; Gian Pietro Ravagnan; Salvatore Metafora; Corrado Rubini; Maria Carteni; Maria Addolorata Mariggiò
Journal:  Oncol Lett       Date:  2011-07-05       Impact factor: 2.967

3.  MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma.

Authors:  Jian Sun; Zhaoli Chen; Xiaogang Tan; Fang Zhou; Fengwei Tan; Yibo Gao; Nan Sun; Xiaohui Xu; Kang Shao; Jie He
Journal:  Med Oncol       Date:  2013-01-05       Impact factor: 3.064

4.  Analysis of a Finnish family confirms RHBDF2 mutations as the underlying factor in tylosis with esophageal cancer.

Authors:  Silva Saarinen; Pia Vahteristo; Rainer Lehtonen; Kristiina Aittomäki; Virpi Launonen; Tuula Kiviluoto; Lauri A Aaltonen
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

5.  Copy number gains of chromosome 17 identified by dual in situ hybridization in non-small cell lung cancer tissue correlate with overexpression of c-Myc.

Authors:  Patrapim Sunpaweravong; Patcharaporn Thongwatchara; Rassamee Chotipanvithayakul; Surasak Sangkhathat; Paramee Thongsuksai
Journal:  Transl Cancer Res       Date:  2022-05       Impact factor: 0.496

6.  Novel microsatellite markers and single nucleotide polymorphisms refine the tylosis with oesophageal cancer (TOC) minimal region on 17q25 to 42.5 kb: sequencing does not identify the causative gene.

Authors:  Joanne E Langan; Charlotte G Cole; Elisabeth J Huckle; Shaun Byrne; Fiona E McRonald; Lynn Rowbottom; Anthony Ellis; Joan M Shaw; Irene M Leigh; David P Kelsell; Ian Dunham; John K Field; Janet M Risk
Journal:  Hum Genet       Date:  2004-03-09       Impact factor: 4.132

7.  RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome.

Authors:  Diana C Blaydon; Sarah L Etheridge; Janet M Risk; Hans-Christian Hennies; Laura J Gay; Rebecca Carroll; Vincent Plagnol; Fiona E McRonald; Howard P Stevens; Nigel K Spurr; D Timothy Bishop; Anthony Ellis; Janusz Jankowski; John K Field; Irene M Leigh; Andrew P South; David P Kelsell
Journal:  Am J Hum Genet       Date:  2012-01-19       Impact factor: 11.025

8.  Protection from intracellular oxidative stress by cytoglobin in normal and cancerous oesophageal cells.

Authors:  Fiona E McRonald; Janet M Risk; Nikolas J Hodges
Journal:  PLoS One       Date:  2012-02-16       Impact factor: 3.240

9.  HN1 interacts with γ-tubulin to regulate centrosomes in advanced prostate cancer cells.

Authors:  Lokman Varisli; Aadil Javed; Bilge Esin Ozturk; Gencer Kaan Akyuz; Gulevin Takir; Fani-Marlen Roumelioti; Sarantis Gagos; Kutsal Yorukoglu; Kemal Sami Korkmaz
Journal:  Cell Cycle       Date:  2021-08-12       Impact factor: 5.173

10.  Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.

Authors:  R J Shaw; T Liloglou; S N Rogers; J S Brown; E D Vaughan; D Lowe; J K Field; J M Risk
Journal:  Br J Cancer       Date:  2006-02-27       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.